Advertisement

Topics

Clontech Laboratories, Inc Company Profile

18:59 EDT 22nd June 2018 | BioPortfolio

Clontech Laboratories, Inc. develops, produces, and markets innovative biological products to the life science market worldwide. Clontech is a wholly owned subsidiary of Takara Bio, Inc.

Location

1290 Terra Bella Avenue
Mountain View
California
94043
United States of America

Contact

Phone: 800-662-2566
Fax: 650-424-1352
Email: orders@clontech.com


News Articles [236 Associated News Articles listed on BioPortfolio]

Clontech Laboratories, Inc.

Clontech Laboratories provides kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. As the newest member of the Takara Bio Group, Clonte...

Reviewing IDEXX Laboratories (IDXX) & The Competition

IDEXX Laboratories is one of 25 publicly-traded companies in the "Diagnostic substances" industry, but how does it contrast to its rivals? We will compare IDEXX Laboratories to related businesses base...

Reviewing Impax Laboratories

Impax Laboratories and Corcept Therapeutics are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, in...

Critical Comparison: Impax Laboratories

Impax Laboratories and Innocoll are both small-cap pharmaceuticals - nec companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk,...

Global and China Protein Purification and Isolation Market Research by Company, Type Application 20132025 [Report Updated: 06032018] Prices from USD $2000

SummaryMarket Segment as follows:By Type 3m 46 m 79 m 1012 m 1315m >15mBy Application Drug screening Biomarker discovery Proteinprotein interaction studies Diagnostics ...

Zacks: Brokerages Anticipate Impax Laboratories Inc (IPXL) Will Announce Earnings of $0.12 Per Share

Analysts forecast that Impax Laboratories Inc will post earnings per share of $0.12 for the current quarter, Zacks reports. Five analysts have made estimates for Impax Laboratories' earnings.

Brokers Issue Forecasts for Impax Laboratories Inc's Q1 2018 Earnings

Impax Laboratories Inc - Analysts at SunTrust Banks issued their Q1 2018 earnings estimates for Impax Laboratories in a report issued on Wednesday. SunTrust Banks analyst J. Boris expects that the spe...

Bionik Laboratories Issues Letter to Stockholders

I joined Bionik Laboratories as CEO in September 2017, having served as a director of the Company for the previous two months.  A focus Read more...

PubMed Articles [170 Associated PubMed Articles listed on BioPortfolio]

Repeatability and variability of total T4 measurements at three German veterinary laboratories.

To evaluate the reproducibility of serum testing for total thyroxine (T4) in three German laboratories.

Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.

Increasingly used for clinical purposes, genome and exome sequencing can generate clinically relevant information that is not directly related to the reason for testing (incidental or secondary findin...

Cell-Free DNA Analysis in Maternal Blood: Differences in Estimates between Laboratories with Different Methodologies Using a Propensity Score Approach.

To evaluate the failure rate and performance of cell-free DNA (cfDNA) testing, mainly in terms of detection rates for trisomy 21, performed by 2 laboratories using different analytical methods.

The American Society for Clinical Pathology's 2016-2017 Vacancy Survey of Medical Laboratories in the United States.

To determine the extent and distribution of workforce shortages within the nation's medical laboratories.

Mapping of the US Domestic Influenza Virologic Surveillance Landscape.

Influenza virologic surveillance is critical each season for tracking influenza circulation, following trends in antiviral drug resistance, detecting novel influenza infections in humans, and selectin...

Clinical Trials [254 Associated Clinical Trials listed on BioPortfolio]

A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal

The objectives of this study are to compare the efficacy and safety of Clotrimazole troche/ lozenges USP, 10 mg (Unique Pharmaceutical Laboratories, India) vs. Clotrimazole Troche/ Lozenge...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fed condi...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fasting c...

Companies [956 Associated Companies listed on BioPortfolio]

Clontech Laboratories, Inc

Clontech Laboratories, Inc. develops, produces, and markets innovative biological products to the life science market worldwide. Clontech is a wholly owned subsidiary of Takara Bio, Inc.

BD Clontech

Clontech Laboratories, Inc. develops, produces, and markets innovative biological products to the life science market worldwide. Clontech is a wholly owned subsidiary of Takara Bio, Inc.

Clontech Laboratories, Inc.

Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., develops, manufactures, and distributes a wide range of life science research reagents under the Clontech and Takara brands. ...

Clontech Laboratories Incorporated

Clontech Laboratories provides kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. As the newest member of the Takara Bio Group, Clonte...

Clontech

Provider of GFP, GAL4, cell cycle, phosphoamino acid, phosphokeratin, and other antibodies, as well as many other innovative molecular and cell biology-related products

More Information about "Clontech Laboratories, Inc" on BioPortfolio

We have published hundreds of Clontech Laboratories, Inc news stories on BioPortfolio along with dozens of Clontech Laboratories, Inc Clinical Trials and PubMed Articles about Clontech Laboratories, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Clontech Laboratories, Inc Companies in our database. You can also find out about relevant Clontech Laboratories, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record